Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?

doi:10.1016/s0895-7061(98)00105-8

Back to search

Article

Will angiotensin converting enzyme genotype, receptor mutation identification, and other miracles of molecular biology permit reduction of NNT?

American journal of hypertension - 1 Aug 1998

Materson B J

Abstract excerpt

Severe forms of hypertension demand treatment because they have a high incidence of morbidity and mortality that can be reduced by antihypertensive therapy. Stage 1-2 hypertension has a low morbidity and mortality; short-term benefits of treatment are harder to document. Managed care organization...

Topics

Genotype
Humans
Hypertension
Polymorphism, Genetic
Receptors, Cell Surface
Renin
Risk Assessment
Sample Size

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.